Meda

Activities: Manufacturing Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

Mylan to acquire Meda in US$9.9bn cash and stock deal

Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products
Manufacturing

DPT Laboratories acquires Meda Pharmaceuticals New Jersey facility

Will meet the current need for additional cold storage and a larger analytical laboratory
Finance

Meda to acquire Rottapharm for around €3bn in cash and shares

Expanding its business in consumer healthcare products and in emerging markets
Finance

Meda to acquire Acton Pharmaceuticals for US$135m

Transaction includes the Aerospan inhaler for the treatment of asthma
Research & Development

Meda expands collaboration with Cipla

Expands its exclusive rights to allergic rhinitis treatment Dymista
Subscribe now